2016
DOI: 10.13057/biodiv/d170236
|View full text |Cite
|
Sign up to set email alerts
|

Antidiabetic screening of some Indonesian marine cyanobacteria collection

Abstract: Cyanobacteria have been known as a potential extracellular-polysaccharide (EPS) producer. The objective of this study was to screen the marine cyanobacteria as potential antidiabetic agents. The present investigation was designed to determine the antidiabetic activity of EPS, intracellular-polysaccharide (IPS) and biomass extracts from marine cyanobacteria isolates. 10 cyanobacteria isolates were cultivated in IMK medium, at 25 o C for 21 days. The morphology of cells was identified by a light microscope. EPS … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 13 publications
0
12
0
Order By: Relevance
“…Other α-glucosidase inhibitory compounds identified in cyanobacteria are present in biofilms [ 32 ], including the extra and intracellular polysaccharides [ 37 ], the latter with action well below that observed in methanolic extracts, with the greatest anti-α-glucosidase action, 14%, detected in extracellular polysaccharides from Pseudanabaena sp., in Synechococcus sp. ; these polysaccharides inhibited 3% of α-glucosidase, suggesting that the inhibitory activity of GFB01 might have another origin.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Other α-glucosidase inhibitory compounds identified in cyanobacteria are present in biofilms [ 32 ], including the extra and intracellular polysaccharides [ 37 ], the latter with action well below that observed in methanolic extracts, with the greatest anti-α-glucosidase action, 14%, detected in extracellular polysaccharides from Pseudanabaena sp., in Synechococcus sp. ; these polysaccharides inhibited 3% of α-glucosidase, suggesting that the inhibitory activity of GFB01 might have another origin.…”
Section: Discussionmentioning
confidence: 99%
“…With occurrence in animals, plants and microorganisms [ 24 , 25 , 26 , 27 ], the bioprospection of glucosidase inhibitors in sustainable natural sources was once concentrated on macroalgae [ 28 , 29 , 30 ] but it is interesting to look for alternatives with cheaper cultivation and that require less area, such as microalgae, including cyanobacteria [ 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. The possibility of associating the production of these inhibitors with other metabolites of biotechnological interest produced by cyanobacteria, such as antioxidants [ 38 ]; pigments [ 39 ], acids and polysaccharides of cosmetic and pharmacological interest [ 40 , 41 ] in addition to joint production with polyhydroxybutyrate (PHB) [ 42 , 43 ] and biofuels [ 44 , 45 , 46 ], while mitigating CO 2 [ 43 , 44 ], is yet another advantage of this bacterial phylum.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diabetes is a metabolic disease characterized by having high concentration of glucose in blood [21]. The management of this metabolic disorder is done by lowering the postprandial increase in blood glucose levels via inhibition of important carbohydrate-degrading enzyme (α-glucosidase), responsible for the breakdown of complex carbohydrates into glucose [22].…”
Section: α-Glucosidase Inhibition Activitymentioning
confidence: 99%
“…and Pseudanabaena sp. produced higher yields than other marine cyanobacteria cultures, yielding biomass yields very low (Priatni et al, 2016). Seawater cultivation has also been carried out on Chaetoceros sp.…”
Section: Cultivation and Potential Wastewater Treatmentmentioning
confidence: 99%